🇺🇸 FDA
Patent

US 7771715

Recombinant vector expressing multiple costimulatory molecules and uses thereof

granted A61KA61K2039/57A61K2239/31

Quick answer

US patent 7771715 (Recombinant vector expressing multiple costimulatory molecules and uses thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/57, A61K2239/31, A61K2239/38, A61K35/12